戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 fugees entering the United States during the observation period).
2  of serotype 5 infection occurred during the observation period).
3 ients, ranibizumab 0.5 mg) through month 12 (observation period).
4 sed their HADS scores by 6 points during the observation period.
5 d in 5, it was performed with an intervening observation period.
6 oad delivered to the coastal zone during the observation period.
7                 No implant failed during the observation period.
8 imately 25,000 paired tests over the 13-year observation period.
9  SCCS design is short relative to the entire observation period.
10 .2 mo), with 228 deaths occurring during the observation period.
11 eaked toward the hydrosphere during the 30-y observation period.
12 recipitates formed remained small during the observation period.
13  exacerbations were assessed over a 24-month observation period.
14 cal behaviors as well as a 6-month wait-list observation period.
15 s occurring during a 42-day postimmunization observation period.
16 50% of the 5-mg TAC recipients surviving the observation period.
17 d to small increases in plant sizes over the observation period.
18 omalizumab or placebo, followed by a 16-week observation period.
19  These changes were sustained throughout the observation period.
20  or 300 mg or placebo, followed by a 16-week observation period.
21 postinfection and persisted through the 4-mo observation period.
22 tion phase, to up to 72.6% at the end of the observation period.
23 entified 6,880 SMI cases (242 deaths) in the observation period.
24 95% CI: 0.02, 0.24; P = 0.02) over the whole observation period.
25 ry 24 hrs during the 96-hr postresuscitation observation period.
26 ferences remained significant throughout the observation period.
27 s 2.3 years and 214 patients died during the observation period.
28 esent; or (d) to reduce the interexamination observation period.
29 der, each over 2.5 months, after a 1.5-month observation period.
30 logic assessment were evaluated over a 7-day observation period.
31 esions and scratching bouts during the whole observation period.
32 rolimus with placebo, followed by a 12-month observation period.
33 resent; or d) to reduce the interexamination observation period.
34 or 8 weeks, followed by an additional 4-week observation period.
35 ntigens (p = 0.005) increased over the 12-mo observation period.
36 uous decrease was observed during the entire observation period.
37 ulation and remained elevated throughout the observation period.
38  higher presynaptic site density over a 24 h observation period.
39 replacement of pups was followed by a 15-min observation period.
40 , which largely recovered during the 24-week observation period.
41 ction and lasting until the fifth day of our observation period.
42 e relapses in MAP-treated mice over a 60-day observation period.
43 enforced in all subjects during the 12-month observation period.
44 m volume increased among all groups over the observation period.
45 T cells and ED1+ macrophages over the entire observation period.
46 ssed in the surrounding areas throughout the observation period.
47  FERG displayed minor changes throughout the observation period.
48 MV immunity was maintained during the 1-year observation period.
49 antage in P. berghei infection over a 30-day observation period.
50 ter OPG-Fc delivery and remained low for the observation period.
51 in blood samples obtained during the 96-hour observation period.
52 80 alone remained normal throughout a 14-day observation period.
53 %, 5%, and 20% CO-saline infusion during the observation period.
54 ation during ground locomotion over a 5-week observation period.
55 as markedly depressed throughout the 48-hour observation period.
56            Nineteen patients died during the observation period.
57 nd severity was comparable at the end of the observation period.
58 rths and 629 deaths were reported during the observation period.
59 pecified disease activity, and length of the observation period.
60 eased by 1.8% per year over the 1983 to 1999 observation period.
61 forced in all the patients during the 1-year observation period.
62 cific T cell repertoire did not occur in the observation period.
63  value for cLCAL/cPD throughout the 30-month observation period.
64 ulation and remained elevated throughout the observation period.
65 y girdling or trenching through the 14-month observation period.
66 ediction for LCAL/PD throughout the 30-month observation period.
67 ion, which resolved by the end of the 14-day observation period.
68 in the same mode of diffusion throughout the observation period.
69 periods of prostitution and during the whole observation period.
70 Cy-annexin injection and remained for a 20-h observation period.
71 ingle wavenumber and persists throughout the observation period.
72 ls remaining patent at the end of the 40-min observation period.
73 rug was withdrawn from the market during the observation period.
74 lus blood flow was maintained throughout the observation period.
75 t concurrently in every pig sampled over the observation period.
76 ifferences between the groups over the 12-mo observation period.
77 , and within individuals over the 12-13 week observation period.
78 ays a week for 2 weeks, followed by a 4-week observation period.
79 s, which were maintained during the off-drug observation period.
80 developed lymphoid tumors during the 60-week observation period.
81 forced in all the patients during the 1-year observation period.
82 t was not detected in the MLN throughout the observation period.
83 plantation (BMT) until the end of the 85-day observation period.
84 um channel blockers at least once during the observation period.
85  reduced in the MBP-fed mice over the 40-day observation period.
86 ny physical signs of toxicity throughout the observation period.
87 e to glucose at any concentration or for any observation period.
88 thod to account for use before and after the observation period.
89 lting in similar overall survival within the observation period.
90 asures appeared relatively stable during the observation period.
91 0 adults who started chemotherapy during the observation period.
92 ends and/or turning points in RUE during the observation period.
93  observed in the argon group over the entire observation period.
94 CD14(dim)CD16(+) monocytes during the 30-min observation period.
95 through visit and pharmacy claims during the observation period.
96  vision to be assessed in a relatively short observation period.
97 ain pooled estimates during each year of the observation period.
98  in some participants over the 2- to 3-month observation period.
99 aintained a VAS score of 0 during the 3-year observation period.
100  autofluorescence background and with a long observation period.
101 did not show any dramatic changes during the observation period.
102 n compared with that of the OM group at both observation periods.
103 nce between the two groups at 6- and 9-month observation periods.
104 %) in the 1998 cohort stopped working in the observation periods.
105 cules is severely constrained, allowing long observation periods.
106 e small number of participants and the short observation periods.
107 ays after hospitalizations than during other observation periods.
108 nce during the treatment and once during the observation periods.
109                           During the 10-year observation period, 1034 subjects (19.1%) developed NIR.
110 ow-up period (121 nonusers) vs >/=50% of the observation period (174 aspirin users).
111 of the 3957 patients (60.3%) died during the observation period: 1812 (57.4%) patients with no cognit
112 d with cardiovascular disease over a 10-year observation period (2000-2010, 90 incident events).
113                      Costs for the index and observation period (2004 to 2008) hospitalizations were
114 scales) on all-cause mortality over a 4-year observation period (2007-10) using Cox regression.
115  spontaneous motor activity (during a 10-min observation period) 21.5% of the time.
116                             During the whole observation period, 21 events occurred: progressive lymp
117 d that ROS production was sustained over the observation period (24 h postinfection).
118                                   During the observation period, 3,007 individuals remained married a
119                Over up to 11,029 such person-observation periods (77,534 person-years), we documented
120 hundred thirty-four SSc patients entered the observation period a mean +/- SD of 0.8 +/- 0.3 years af
121 his study tested the hypothesis that a 2-min observation period after asystole is sufficient for the
122                               During a 4-day observation period after cecal ligation and puncture, on
123 y testing should be considered and a minimum observation period after rewarming before brain death te
124 iption for any medication during the 150-day observation period after the low LDL value.
125                           During the 6-month observation period after treatment, median days to first
126 sed the risk of developing KS throughout all observation periods after cART initiation.
127 everity and support recommendations for safe observation periods after initial treatment.
128 ion of lorazepam infusion was 2 days for the observation period and 0 days for the intervention perio
129 intravenous plus enteral) was 7 days for the observation period and 5 days for the intervention perio
130 tion of morphine infusion was 6 days for the observation period and 5 days for the intervention perio
131 f vernakalant (3 mg/kg) followed by a 15-min observation period and a second 10-min infusion (2 mg/kg
132 Cs persisted in the grafts throughout a 3 wk observation period and allowed noninvasive MR imaging of
133 were recovered from 21 pigs over the 367-day observation period and compared to the original plaque-c
134  red cell velocity decreasing throughout the observation period and dropping to <5% of the starting v
135 d 0.3801 life-years relative to PCI over the observation period and lifetime, respectively.
136 ere similar among prior living donors in the observation period and nondonor controls (rate ratio, 0.
137 y design enabled a short trial with a 2-year observation period and provided data that can be used to
138 eiving treatment as usual completed a 4-week observation period and were randomly assigned to 12 week
139 reported, with the potential to decrease the observation periods and admissions for approximately 40%
140 erapy (ART) programs is complicated by short observation periods and loss to follow-up.
141 h assistants observed each nurse for two 3-h observation periods and recorded data on a researcher de
142 olates with a single genotype throughout the observation period, and others had intervening or sequen
143 xtractions, pretreatment age, post-treatment observation period, and pretreatment KT height.
144 were within the control range throughout the observation period, and there were no systematic interoc
145 ason length increased progressively over the observation period, and this shift was accelerated in mo
146 esting with each examination separated by an observation period are required.
147 hanges in yearly phenotypes based on regular observation periods are considered to represent multiple
148 esting with each examination separated by an observation period, are required.
149 ay risk interval, using the remainder of the observation period as the control interval, was signific
150                     At the conclusion of the observation period, averages were pH, 7.29 +/- 0.05; res
151 tients per dose cohort and allowing a 2-week observation period before dose escalation.
152 One hundred fifty-five Zimbabwean women with observation periods before and after HIV acquisition and
153                             During the whole observation period, both groups showed comparable clinic
154 line in the total scores by 13.8% during the observation period but an improvement by 11.4% (P < 0.00
155  the emergency department and throughout the observation period but did not differ from the group wit
156 ated with lower EDSS scores over the 10-year observation period (coeff = -0.36, p = 0.009).
157  in the slowest HRR quartile died during the observation period compared with 14 participants in the
158 ower risk of colon cancer during the 8 month observation period, compared with infected mice that had
159  were exposed to fluoroquinolones during the observation period, corresponding to 80 cases exposed du
160 l death, loss to follow-up or the end of the observation period (December 31, 1998).
161 atment has no effect over a twenty-eight-day observation period despite clearing fecal colonization a
162 ividuals became infected during the 14-month observation period, documenting continuing virus spread
163                             After an initial observation period, dogs were treated with or without si
164                           The portion of the observation period during which the coronary artery was
165 rpose we defined a new covariate summing the observation periods during which each individual contrib
166 ported among the three groups during the two observation periods (early period: days 1, 3, and 7; and
167                          Across the 5-decade observation period, edentulism prevalence declined from
168                                     The last observation period ended on December 31, 2008.
169 e decrease was progressive during the entire observation period, except during 1990-2000, when a plat
170  in the Hepa Wash group survived the 13-hour observation period, except for one that died after stopp
171 increased in size and flower number over the observation period, five of the seven species decreased
172 AF with an initial 3-month noninterventional observation period followed by twice-weekly 60-min yoga
173                     After a 5-month baseline observation period, four classes of antimicrobial agents
174 gnificant changes could be detected over the observation period from baseline in the EC users or betw
175 rthday, which took place during this study's observation period from January 1, 1982, through Decembe
176  the type of local regional therapy, minimal observation period from successful tumor down-staging to
177 0.93]; p = 0.0056) than with warfarin in the observation period &gt;18 months.
178 survived without evidence of disease for the observation period (&gt;1 year), whereas mice that received
179  the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years
180  of developing CDMS by 32.2% over the 8-year observation period (HR 0.678; 95% CI 0.525 to 0.875; p=0
181  in cases versus controls during the overall observation period (HR, 5.2 for any ocular complication;
182 t patients had medication available over the observation period (ie, days covered); women with fewer
183 rom the emergency department after a 12-hour observation period if they do not have evidence of ische
184 ree of retinopathy was stable throughout the observation period in 68 of 74 eyes, improved in 4, and
185         The mean values decreased during the observation period in both groups; statistically signifi
186     Tmin , for example, decreased across the observation period in coastal regions, but increased in
187 tion did not change significantly during the observation period in either study group.
188 ively evaluated the safety of a 9-to-12-hour observation period in patients with cocaine-associated c
189                     All animals survived the observation period in the mild therapeutic hypothermia 1
190                        Here, we extended the observation period in this long-term experiment by an ad
191  that may be related to the relatively short observation period in this study and the high frequency
192 n the immunosuppression regimen did over the observation period in this study.
193 tion rates remained unchanged throughout the observation period in units A and B; however, unit C had
194 ied during the combined trial and post-trial observation periods in contrast to 34 of 120 patients (2
195  did not differ between the first and second observation periods in untreated dogs (49 +/- 11% vs. 44
196                                   During the observation period, incident diabetes was reported by 54
197 d autoresuscitation during the 5-min waiting observation period, including the first 2 mins after asy
198 S intervention, implemented after a baseline observation period, informed providers who placed an ord
199 s, added either once or weekly over the 6-wk observation period, inhibited bacterial growth by up to
200 ased methodology for segmenting individuals' observation periods into visits to places and trips, ena
201 citation in our series suggests that a 2-min observation period is sufficient for the determination o
202 leeding manifestation since the last visit" (observation period) is graded (a suitable database colle
203 eir melanoma metastasized, by the end of the observation period (mean follow-up after diagnosis of me
204 us leg ulcers is challenged by the prolonged observation period necessary to reach the endpoint of he
205 ow vision, it is encouraging that during the observation period neither patient lost vision.
206 o never or rare users (< or =30 pills during observation period), no evidence was observed of increas
207 on between the first and last 4 years of the observation period occurred in the unvaccinated populati
208  having MDA during >or=2 consecutive 6-month observation periods, occurred in 13.5% of 7,433 patients
209                          During a prevaccine observation period of >/=50 years in high-income countri
210 ion time of up to 24 h remains optimal as an observation period of < or = 8 h risks missing > or = 33
211  nervous tissue were not detected during the observation period of 1 year.
212 to a maximum age of 18 years, with a minimal observation period of 1 year.
213 sual acuity between the two groups during an observation period of 12 months.
214  mg/dL) and maintained this level during the observation period of 12 weeks (P<0.05).
215                                 After a mean observation period of 12.6 mo (mean of 26 mo posttranspl
216 ance enrollment was 7.7 years, with a median observation period of 2.1 years.
217 ants who remained event free during a median observation period of 2.9 years.
218                                During a mean observation period of 21 months, disease recurrence occu
219                                           An observation period of 24 hours for term newborns (37 wee
220                                           An observation period of 24 hrs for term newborns (37 wks g
221                                    A minimum observation period of 3 months after down-staging was re
222                                Over a median observation period of 39 (22-52) years, 22 patients (16%
223 and 19.9 months, respectively, with a median observation period of 48 months.
224 s larger than six cells did not close in the observation period of 6 hours, but we observed that basa
225 roups of the entire cohort within the median observation period of 7 years.
226 dies with immunofluorescence during a median observation period of 7.0 years (mean, 6.3 years).
227 61 screening MR imaging studies, covering an observation period of 7007 women-years.
228  HMVEC-d, which was sustained throughout the observation period of 72 h p.i.
229                         During a pooled mean observation period of 8 months (range, 3-12 months), few
230                          During a comparable observation period of 86.2 months (P=0.654), 65 patients
231 tem cell transplant (N = 102) after a median observation period of approximately 3 years.
232                               After a median observation period of approximately 6 years from first t
233 lated survival probability in the first hour observation period of survivors averaged 85 +/- 14% vs.
234 s may be related to the longer treatment and observation period of these observational studies, which
235  severe or serious adverse events during the observation period of this study.
236  the annual rate of arrhythmic events during observation periods of equal duration before and after t
237 sessed visual function preservation, and the observation periods of previous (unmasked) trials have t
238 s, at least two eGFR values available in the observation period (one at baseline and at least one aft
239 inical practice and with a sufficiently long observation period outside the clinical trial scenario.
240 /L at baseline to >135 mmol/L throughout the observation period (P < 0.001 versus baseline at most po
241 as higher in the argon group over the entire observation period (p < 0.05).
242 here was an improved survival throughout the observation period (P = 0.004).
243 s still over 70% at the end of the 119-month observation period (P =.044, Breslow-Gehan log-rank test
244 6.9% at baseline and 56.8% at the end of the observation period (P<0.001 versus ANGELS of AF group).
245                             During an 8-week observation period, participants were encouraged to log
246                                   During the observation period, PBC-related mortality significantly
247 ocial conformity, was sustained for a 2-week observation period post intervention.
248   Results were similar when using the entire observation period, propensity score analysis, and limit
249 hree follow-up visits per patient during the observation period (range, one to six).
250 trophin RNA did not increase after HCT, with observation periods ranging from 28 to 417 days.
251             This approach could decrease the observation period required for some patients with chest
252 oliferation of PECs persisted throughout the observation period, resulting in the formation of typica
253                                  The 365-day observation period showed a small increase in the HR for
254 of smokers and continued to persist over the observation period, suggesting that smoking favors early
255 hormone secretion disappeared over the 40-mo observation period, suggesting that the impact of MPH on
256 volving 30-40 contacts formed during a 1-min observation period, TCR stimulation triggered a rapid an
257 uberculosis-related event within the 6 month observation period that related to a worsening of the un
258 ent with these expectations, over the 3-year observation period the intervention raised African Ameri
259                            During the entire observation period, the c-statistics and negative predic
260                                   During the observation period, the ICU was converted from an open m
261                           At the end of each observation period, the observers printed the alarm even
262                            During a 12-month observation period, the patients' total strength had dec
263                              For most of the observation period, the permeability decreased rapidly a
264 P >0.15) for potential effects regarding the observation period, the type of implant connection, or b
265                            At 6- and 9-month observation periods, the MPM-treated sites showed a stat
266                               After a 90-min observation period there was a return to baseline values
267                                   During the observation period, there were 2740 admissions, 965 of w
268  mean follow-up of 2.0+/-1.4 years after the observation period, there were 510 deaths.
269                                   During the observation period, there were no dysrhythmia adverse ev
270                     In the post-intervention observation period, this difference was not statisticall
271 s-associated systemic illness, the end of an observation period, use of the other class of antibiotic
272 , and cancer-specific mortality for a 7-year observation period using the number of deaths observed i
273  spontaneous locomotor activity over a 5-min observation period, using a recently designed metric (pL
274  spontaneous locomotor activity over a 5-min observation period, using a recently designed metric.
275 sk of amyotrophic lateral sclerosis over the observation period was 0.5% for siblings and 1.0% for of
276                                          The observation period was 1 yr, and the trial was open labe
277  performed procedures as well as in a 30-day observation period was 100% in case of stenosis and 80%
278                                   The median observation period was 14 months.
279                                          The observation period was 2 years, with subjects monitored
280                                         Mean observation period was 8 years (range: 0.6-23 years).
281 abnormal cervical cytology result during the observation period was lower among vaccinated (>/=1 dose
282       In addition, the highest Tb during the observation period was not measured during nursing behav
283  data, consisting of 4 noncontiguous 1-month observation periods, was used to examine the relationshi
284  recurrent symptoms) during the 9-to-12-hour observation period were discharged from the unit.
285 dicare reimbursement rates; costs beyond the observation period were estimated from average Medicare
286           Hospitalizations during a 24-month observation period were identified using hospital record
287 t least one dose of FCM intravenously in the observation period were included in this analysis with d
288 andomized controlled trials with a long-term observation period were included.
289                                              Observation periods were divided into four 12-month inte
290  18 years), measured at the beginning of the observation period, were ranked by Ab signal intensity.
291 CU nurse's activities and tasks, during 4-hr observation periods, were categorized in real-time by a
292 ice remained HCV-RNA negative throughout the observation period, whereas the other 3 had a viral load
293 is pattern of dispersion for the rest of the observation period, while HCV variants in the other two
294 gal burdens remained constant throughout the observation period, while polymorphonuclear leukocyte (P
295 ined alive and healthy throughout the 85-day observation period, with a cumulative survival probabili
296 ected vegetation productivity throughout the observation period, with a general worsening of the drou
297 ve multifocal leukoencephalopathy during the observation period, with complete recovery.
298 ce rate of any first OI decreased over the 3 observation periods, with 3.0 cases, 2.4 cases, and 1.5
299 n preventing breast cancer mortality with an observation period within 1983 and 1993, with mortality
300 of resiquimod-treated patients completed the observation period without a recurrence, compared with 6

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top